sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]
RxNorm concept 2626375, branded drug (sbd). Prescribable name: OLPRUVA 2 GM Granules for Oral Suspension.
- RxCUI
- 2626375
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626375 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- sodium phenylbutyrate 2000 MG (SCDC, consists of)
- sodium phenylbutyrate 2000 MG [Olpruva] (SBDC, consists of)
- {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 2 GM Pack] (BPCK, contained in)
- {2 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 4 GM Pack] (BPCK, contained in)
- {1 (sodium phenylbutyrate 2000 MG Granules for Oral Suspension [Olpruva]) / 1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 5 GM Pack] (BPCK, contained in)
- Granules for Oral Suspension (DF, has dose form)
- Olpruva (BN, has ingredient)
- sodium phenylbutyrate 2000 MG Granules for Oral Suspension (SCD, tradename of)
Linked data
NDCs
- 72542000201
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2626375 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2626375 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2626375. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.